Page last updated: 2024-08-21

carbon tetrabromide and Cirrhosis, Liver

carbon tetrabromide has been researched along with Cirrhosis, Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dong, F; Song, D; Tian, H; Wu, H; Wu, W; Zeng, J; Zhang, L1
Calabro, SR; d'Avigdor, W; Lee, M; Locarnini, SA; Maczurek, AE; McCaughan, GW; McLennan, SV; Morgan, AJ; Mridha, A; Shackel, NA; Tu, T; Warner, FJ; Wen, VW; Yee, C1

Other Studies

2 other study(ies) available for carbon tetrabromide and Cirrhosis, Liver

ArticleYear
Knockdown of TXNDC5 alleviates CCL4-induced hepatic fibrosis in mice by enhancing endoplasmic reticulum stress.
    The American journal of the medical sciences, 2023, Volume: 366, Issue:6

    Topics: Animals; Collagen; Disease Models, Animal; Endoplasmic Reticulum Stress; Fibrosis; Hepatic Stellate Cells; Liver Cirrhosis; Mice; Transforming Growth Factor beta1

2023
Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Animals; Basigin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Hepatocytes; Humans; Hydrocarbons, Brominated; Immunohistochemistry; Liver; Liver Cirrhosis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Tissue Inhibitor of Metalloproteinases

2014